SS Innovations International Inc (SSII)
SS Innovations International, Inc. is a commercial-stage healthcare company focused on surgical robotics and related technologies. Through its subsidiaries, the company serves markets in India and several international regions, including the Philippines, Indonesia, South America, Iraq, Cyprus, Oman, the United Arab Emirates, and Nepal. Its core product lineup includes the SSi Mantra surgical robotic system and the SSi Mudra family of stapling, energy, and core instrumentation designed for use with surgical systems. The company also develops a range of adjacent technologies and devices, such as the NADI automated coronary anastomotic connector, robotic stapling and clip-applying tools, digital and tele-mentoring platforms, XR-based surgeon training software, augmented and mixed reality products, and an AI-enabled DICOM viewer. In addition, it provides instrument tips, accessory products, telesurgery and tele proctoring offerings, and technical services including installation, maintenance, repair, and 24/7 support. The company is headquartered in Gurugram, India, and its common stock is listed on NASDAQ under the ticker SSII.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SSII
|
—
|
—
|
—
|
$7
|
90.2% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-73.4x
|
13.5x
|
15.2x
|
750.5 M
|
734.3 M
|
1.8%
|
20.1%
|
5.2
|
—
|
175.4%
|